Article Versions Notes

Brunetti O, Gnoni A, Licchetta A, Longo V, Calabrese A, Argentiero A, Delcuratolo S, Solimando AG, Casadei-Gardini A, Silvestris N. Predictive and Prognostic Factors in HCC Patients Treated with Sorafenib. Medicina. 2019; 55(10):707. https://doi.org/10.3390/medicina55100707

Brunetti, Oronzo, Antonio Gnoni, Antonella Licchetta, Vito Longo, Angela Calabrese, Antonella Argentiero, Sabina Delcuratolo, Antonio Giovanni Solimando, Andrea Casadei-Gardini, and Nicola Silvestris. 2019. "Predictive and Prognostic Factors in HCC Patients Treated with Sorafenib" Medicina 55, no. 10: 707. https://doi.org/10.3390/medicina55100707

Brunetti, O., Gnoni, A., Licchetta, A., Longo, V., Calabrese, A., Argentiero, A., Delcuratolo, S., Solimando, A. G., Casadei-Gardini, A., & Silvestris, N. (2019). Predictive and Prognostic Factors in HCC Patients Treated with Sorafenib. Medicina, 55(10), 707. https://doi.org/10.3390/medicina55100707